Publication | Closed Access

IN FOCUS: A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity – a staphylokinase variant. I. In vitro study

ThrombosisIn FocusBlood PlateletMedicineHematologyFibrinolysisVascular BiologyProtein EngineeringBiomedical EngineeringPharmacologyAnticoagulantStaphylokinase VariantHigher Fibrin Affinity